Areas of expertise: Ewing sarcoma, EWS-FLI1, translational sarcoma therapies
Dr. Grohar received his B.S. in chemistry from Villanova University followed by his Ph.D. in chemistry and his M.D. from Wayne State University in Detroit, Michigan. He then completed a residency at Johns Hopkins University followed by fellowship training in pediatric hematology oncology at Johns Hopkins and the National Cancer Institute, where he also served as a junior faculty member. After NCI, he joined the faculty at Vanderbilt University as an assistant professor of pediatrics before arriving at Van Andel Research Institute as an associate professor in July 2015.
In addition to his appointment in VARI’s Center for Cancer and Cell Biology, Dr. Grohar maintains a clinical presence in the department of hematology/oncology at Spectrum Health Helen DeVos Children’s Hospital, where he is a member of the sarcoma team. He also has an academic appointment at Michigan State University in the Department of Pediatrics. He is a member of the Children’s Oncology Bone Tumor Steering Committee and vice-chair of the Ewing Sarcoma Biology Committee of the Children’s Oncology Group.